Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiation: Applications01:17

Radiation: Applications

The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The development of practice standards for radiation oncology in Australia: a tripartite approach.

Clinical oncology (Royal College of Radiologists (Great Britain))·2015
Same author

Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy.

The British journal of radiology·2012
Same author

Prospective development of an individualised predictive model for treatment coverage using offline cone beam computed tomography surrogate measures in post-prostatectomy radiotherapy.

Journal of medical imaging and radiation oncology·2009
Same author

Implementation of daily image-guided radiation therapy using an in-room CT scanner for prostate cancer isocentre localization.

Journal of medical imaging and radiation oncology·2009
Same author

A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09.

International journal of radiation oncology, biology, physics·2000
Same author

Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999

Related Experiment Video

Updated: Jul 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Radiation for prostate cancer.

G M Duchesne1

  • 1Monash University, Melbourne, Australia. gillian.duchesne@med.monash.edu.au

The Lancet. Oncology
|March 22, 2002
PubMed
Summary

Technological advances in radiotherapy for prostate cancer enable dose escalation, reducing normal tissue damage and potentially improving tumor control. Evidence suggests this approach offers survival rates comparable to surgery.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Conventional radiotherapy for localized prostate cancer faces challenges in balancing tumor control with normal tissue damage.
  • Technological advancements permit minimizing radiation exposure to healthy tissues.
  • Reduced normal tissue toxicity allows for dose escalation, potentially enhancing anti-tumor efficacy.

Purpose of the Study:

  • To review methods for dose escalation in prostate cancer radiotherapy.
  • To evaluate the safety and efficacy of dose-escalated radiotherapy compared to conventional treatments.
  • To assess the impact of dose escalation on patient outcomes, including survival rates.

Main Methods:

  • Discussion of techniques used for dose escalation in prostate cancer radiotherapy.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Related Experiment Videos

Last Updated: Jul 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

  • Review of existing evidence on the safety and efficacy of dose-escalated regimens.
  • Comparison of outcomes with conventional radiotherapy and surgical series.
  • Main Results:

    • Dose escalation strategies have been developed and implemented.
    • While randomized trials demonstrating improved survival are lacking, available data suggest equivalence to surgical outcomes.
    • The reviewed evidence supports the safety and efficacy of dose escalation.

    Conclusions:

    • Dose escalation in prostate cancer radiotherapy is a viable strategy.
    • It offers survival rates comparable to surgery, providing a realistic treatment option.
    • Further research, including randomized trials, is needed to definitively establish survival benefits.